Skip to main content
logo
YD Bio Limited (YDES)
NASDAQ: YDES · Real-Time Price · USD
2.295
-0.069 (-2.92%)
At close: Aug 7, 2026, 4:00 PM EDT
2.290
-0.005 (-0.22%)
After-hours: Aug 7, 2026, 5:05 PM EDT

YD Bio Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22
Revenue
0.60.60.510.350.36
Revenue Growth
16.94%16.94%45.76%-3.81%-
Gross Profit
0.170.170.160.150.13
Operating Income
-5.27-5.27-1.46-0.01-0.05
Net Income
-8.31-8.31-1.410.01-0.05
Earnings Per Share
-0.12-0.12-1.290.00-0.05
EPS Growth
-----

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023
Period EndingDec '25 Dec '25 Dec '24 Dec '23
Cash & Investments
6.016.013.130.09
Total Debt
0.010.010.020.05
Net Cash (Debt)
663.110.04
Net Cash Growth
92.95%92.95%7769.12%-
Net Cash Per Share
0.090.092.840.00

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22
Operating Cash Flow
-6.6-6.6-1.22-0.060.07
Capital Expenditures
-1.44-1.44-0.07-0-
Free Cash Flow
-8.04-8.04-1.3-0.060.07
Free Cash Flow Growth
-----

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22
Gross Margin
28.05%28.05%30.44%43.82%36.54%
Operating Margin
-883.31%-883.31%-286.45%-2.81%-12.36%
Pretax Margin
-1392.86%-1392.86%-271.67%5.04%-13.46%
Profit Margin
-1392.61%-1392.61%-276.58%3.87%-14.01%
FCF Margin
-1346.60%-1346.60%-254.25%-15.98%19.22%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22
PS Ratio
316.221445.87---